48MO SQZ-PBMC-HPV-101: Preliminary results of a first-in-human, dose-escalation study of a cell-based vaccine in HLA A02+ patients with recurrent, locally advanced, or metastatic H... von Park, J-C., Baranda, J.C., Mita, M.M., Iams, W.T., Gordon, M.S., Taylor, M., Dhani, N., Loughhead, S.M., Ji, R-R., Zwirtes, R.F., Kornacker, M., Rosen, O., Bernstein, H., Jimeno, A.

Volltext